Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
- Citation:
- Eur J Cancer vol 201 113914
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 3734
- Children:
- None
- Pharmas:
- Bristol-Myers Squibb, Genentech, and Pfizer
- Grants:
- U10CA180821, U10CA180882, UG1CA233163, UG1CA233373, P30CA 014089, U10CA180888, UG1CA180830(SWOG)
- Corr. Author:
- Authors:
- Hiroyuki Arai Yan Yang Yasmine Baca Joshua Millstein Tadamichi Denda Fang-Shu Ou Federico Innocenti Hiroyuki Takeda Yohei Kubota Ayako Doi Yoshiki Horie Kumiko Umemoto Naoki Izawa Jingyuan Wang Francesca Battaglin Priya Jayachandran Sandra Algaze Shivani Soni Wu Zhang Richard M. Goldberg Michael J. Hall Aaron James Scott Jimmy J. Hwang Emil Lou Benjamin A. Weinberg John Marshall Sanjay Goel Joanne Xiu W. Michael Korn Alan P Venook Yu Sunakawa Heinz-Josef Lenz
- Networks:
- CA011, CA824, CAPITAL, LAPS-MN026, LAPS-NC007, LAPS-OH007, MN022, MONTEFIORE, MUSC, NC002, SCOR
- Study
- Alliance-A152108
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80405
- Phases:
- N/A, 3
- Keywords: